Mouse Macrophage Colony stimulating Factor Recombinant

/, PDGF family, Recombinant Mouse Cytokines/Mouse Macrophage Colony stimulating Factor Recombinant

Mouse Macrophage Colony stimulating Factor Recombinant

$70.00$4,700.00


accession P07141


Source Optimized DNA sequence encoding mouse M-CSF extracellular domain was expressed in Escherichia Coli.
Molecular weight Mouse MCSF, generated by the proteolytic removal of the signal peptide and propeptide, The molecule has a calculated molecular mass of approximately 18 kDa. Recombinant Mouse M-CSF is a disulfide-linked homodimeric protein consisting of two 156 amino acid residue subunits, andmigrates as an approximately 37 kDa protein under non-reducing and as 18-19kDa under reducing conditions in SDS-PAGE.
Purity >95%, as determined by SDS-PAGE and HPLC
Biological Activity The ED(50) was determined by the dose-dependent stimulation of the proliferation of of M-NFS-60 cells is < 1.0 ng/ml, corresponding to a specific activity of > 1 x 106 units/mg.
Protein Sequence
Endotoxin Endotoxin content was assayed using a LAL gel clot method. Endotoxin level was found to be less than 0.1 ng/µg(1EU/µg).
Presentation Recombinant mouse MCSF was lyophilized from a 0.2 μm filtered PBS solution.
Reconstitution A quick spin of the vial followed by reconstitution in distilled water to a concentration not less than 0.1 mg/mL. This solution can then be diluted into other buffers.
Storage The lyophilized protein is stable for at least 2 years from date of receipt at -20° C. Upon reconstitution, this cytokine can be stored in working aliquots at 2° - 8° C for one month, or at -20° C for six months, with a carrier protein without detectable loss of activity. Avoid repeated freeze/thaw cycles.
Usage This cytokine product is for research purposes only.It may not be used for therapeutics or diagnostic purposes.


Interactor P03228
Interactor P03228
Interactor P09581 CSF1R_MOUSE
Interactor P46414
Interactor P07333 CSF1R_HUMAN
Biological Process Immunity
Biological Process Inflammatory-response
Molecular function Cytokine
Molecular function Growth-factor

Methods

Lung-derived prominin-1.

M-CSF
  • Exposure of prominin-1+ cells to M-CSF for 7 days resulted in formation of E.coli phagocytising F4/80-positive cells .

Osteoblast, osteoclast and macrophage differentiation.

5 ng/ml M-CSF
  • Bone marrow derived monocytes were seeded in 24-well culture plates and induced to differentiate into macrophages or osteoclasts via the addition of M-CSF or M-CSF + RANKL respectively.

Cell activation assay and immunodetection of cytokines

  • Single spleen cell suspensions were prepared by mechanical disruption on a cell strainer (70 µm pore diameter , , ) in Dulbecco's D-PBS .
  • Red blood cells were lysed using Hemolytic Gey's Solution as previously described

Osteoclastogenesis assays

  • Osteoclastogenesis assays were performed as in 5 cells were plated in each well of a 24-well dish with 60 ng/mL RANKL for 3 days.
  • After 3 days, 2×103 MDA-231, shControl, or shEGFR-MDA-231 cells were plated with the bone marrow cells, with 60 ng/mL RANKL and 10 ng/mL MCSF and grown for 3 days before TRAP staining.
  • For TRAP staining, cells were washed with 1×PBS, fixed with ice cold methanol for 10 minutes, and stained in fresh TRAP solution for 15 minutes at 37°C.
  • TRAP solution was replaced with 1×PBS for cell counting under the microscope.

PLCγ2 is required for in vitro osteoclast development.

10 ng/mL recombinant mouse M-CSF
  • (a) Representative TRAP-stained images of wild-type and PLCγ2−/− bone marrow cells cultured in the presence of the indicated concentrations of recombinant murine M-CSF and RANKL for 4 days.

Generation of conditional TAK1-deficient mice.

M-CSF
  • Colony formation by BM cells from Map3k7

Generation of bone marrow-derived macrophages

  • Bone marrow-derived macrophages (BMDM) were generated by flushing the bone marrow from the femurs of BALB/c mice with RPMI 1640 media.
  • Freshly collected bone marrow cells were cultured overnight in complete media (CM; RPMI 1640, 10% fetal bovine serum [Atlanta, ], 10 mM HEPES buffer, 10 mM nonessential amino acids, 10 mM sodium pyruvate) containing 5 ng/ml recombinant murine M-CSF .
  • The non-adherent cells were then collected and cultured for an additional six days in CM with 30 ng/ml M-CSF to generate macrophages.

Pro-resorptive cytokine expression and osteoclastogenesis in the synovial fluid of patients with gouty arthritis.

M-CSF
  • PBMCs, SFMCs, and T cell-depleted SFMCs (3 × 105 cells/well) were cultured for 10 days in the presence of macrophage colony-stimulating factor (M-CSF; 30 ng/ml) at the different RANKL concentrations and then were stained for tartrate-resistant acid phosphatase .

TcREG inhibit osteoclast activity in an antigen- and contact-independent manner by secreted cytokines.

recombinant murine M-CSF
  • Cells were re-fed with medium containing M-CSF and RANKL every 2 to 3 days.

Induction of 2nd iPSCs

  • All isolated somatic cells were cultured in the presence of Dox (2 ug/ml) for induction of 2nd iPSCs.
  • Fibroblasts and hematopoietic cells were cultured in ES/iPSC medium.
  • FLCD45 were cultured in the presence of 10 ng/ml human TPO, 10 ng/ml mouse EPO, 10 ng/ml mouse IL-3, 10 ng/ml mouse IL-6, 10 ng/ml mouse Flt3 ligand, 10 ng/ml mouse GM-CSF, 10 ng/ml mouse VEGF and 50 ng/ml mouse SCF .
  • HSCs, HPCs and MPs were cultured in the presence of 10 ng/ml human TPO, 10 ng/ml mouse IL-3, 10 ng/ml mouse IL-6 and 10 ng/ml mouse Flt3 ligand .
  • Macrophages were cultured in the presence of 5 ng/ml M-CSF .